A career in cancer research: What industry has to offer
Programme session type(s): Workshop
Date and time: Tue 06-Nov-2018, 18/01/2019 08:15-18/01/2019 09:00
This breakfast career workshop will be hosted by the NCRI Industry Consultation Group and will include representatives from AstraZeneca, Bristol-Myers Squibb, Eisai, Gilead, Pfizer, Roche and Servier.
The workshop will bring together researchers and industry for round table discussions on topics that will include*
•TABLE 1 / How to successfully transition to a position in industry
Host: Hazel Jones, Oncology IMED Chief of Staff, AstraZeneca
•TABLE 2 / Job roles in industry
Host: Abraham Selvan, Medical Science Manager, Oncology, Bristol-Myers Squibb
•TABLE 3 / How can I increase my attractiveness to employers for a career in Medical Affairs?
Host: Ian Brown, Senior Medical Affairs Manager, Oncology Business Group, Eisai Ltd
•TABLE 4 / Maze Mastery: Navigating Your Journey Through Pharma
Host: Harry Smith, Medical Scientist Oncology, Gilead
•TABLE 5 / In the Field Medical Affairs roles – what should I expect?
Host: Sean Buckland, Senior Medical Affairs Advisor, Pfizer Ltd
•TABLE 6 / In the Head office Medical Affairs roles – what should I expect?
Host: Olivia Ashman, UK Oncology Medical Director, Pfizer Ltd
•TABLE 7 / Your Future in Pharma: How to Bridge the Gap
Host: James Mawby, Head of Medical Affairs, Roche Products Limited
•TABLE 8 / Roles in industry with an interest in clinical operations. What are the sought-after skills?
Host: Helen Whitrow, Clinical Research Manager, Servier Laboratories
•TABLE 9 / Working in Medical Affairs and the MSL role: A bridge between pharma and the medical community
Host: Gareth Jones – MSL, Servier Laboratories
Attendees will have a chance to join 2 tables (20 minutes each) and discuss their preferred topics with table hosts and other participants.
Please note, places for this workshop are limited and will be allocated on a first come first served basis.
Breakfast at this workshop has been kindly sponsored by Gilead
*Titles subject to change